{"title":"Growth Hormone \u0026 GH-Releasing Research Peptides UK","description":"\u003cp\u003eOur \u003cstrong\u003egrowth hormone and GH-releasing research peptides\u003c\/strong\u003e collection features compounds studied for their roles in the hypothalamic-pituitary-somatotropic axis, including GH secretagogue receptor (GHS-R) agonism and GHRH-receptor activation. Available to UK researchers for in vitro and preclinical laboratory investigation, this range includes Ipamorelin, CJC-1295 No DAC + Ipamorelin, and Tesamorelin — all produced to ≥99% purity with independent HPLC verification.\u003c\/p\u003e\u003cp\u003eThese compounds are investigated in models of GH secretion kinetics, IGF-1 axis modulation, lipodystrophy, body composition, and pulsatile versus continuous GH release. Tesamorelin is a synthetic GHRH analogue with an established clinical trial history; Ipamorelin is a highly selective GHS-R agonist; CJC-1295 No DAC provides shorter-acting GHRH-receptor stimulation in research models. Available in vial and cartridge formats with CoA documentation.\u003c\/p\u003e\u003cp\u003e\u003cem\u003eAll products are supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary use.\u003c\/em\u003e\u003c\/p\u003e","products":[{"product_id":"cjc-1295-no-dac","title":"Buy CJC-1295 No DAC + Ipamorelin Research Peptide UK","description":"\u003cp\u003e\u003cstrong\u003eCJC-1295 (No DAC) + Ipamorelin\u003c\/strong\u003e is a research peptide combination pairing a GHRH analogue with a selective GHRP to produce synergistic growth hormone secretagogue activity. CJC-1295 (No DAC; CAS 863288-34-0) is a 30-amino-acid GHRH analogue studied for its ability to stimulate pulsatile GH release from pituitary somatotrophs without drug affinity complex (DAC) extension. Ipamorelin (CAS 170851-70-4) is a highly selective pentapeptide GHRP that acts on the ghrelin\/GHS-R1a receptor to potentiate GH secretion with minimal off-target effects on cortisol or prolactin.\u003c\/p\u003e\u003cp\u003eThe combination is studied in preclinical endocrinology research for its ability to model pulsatile GH physiology, investigate somatotroph function, and study downstream IGF-1 and metabolic signalling. The two compounds act via distinct but complementary receptor pathways (GHRH-R and GHS-R1a), making their combination a useful dual-agonist research tool.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCJC-1295 CAS:\u003c\/strong\u003e 863288-34-0  ·  \u003cstrong\u003eIpamorelin CAS:\u003c\/strong\u003e 170851-70-4  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Pulsatile GH release · GHRH-R \/ GHS-R1a dual agonism · Endocrine signalling · IGF-1 pathway · Pituitary somatotroph function · Metabolic research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin: first selective growth hormone secretagogue (PMID 9849822)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/\" target=\"_blank\" rel=\"noopener\"\u003ePK\/PD modelling of ipamorelin in human volunteers (PMID 10496658)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=CJC-1295+ipamorelin+growth+hormone+GHRH\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: CJC-1295 + Ipamorelin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53109168570701,"sku":null,"price":45.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/CJC-1295NODA10mgBox-M.jpg?v=1770812241"},{"product_id":"tesamorelin","title":"Buy Tesamorelin Research Peptide UK | 99%+ Purity","description":"\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), comprising the full 44-amino acid sequence of GHRH with a trans-3-hexenoic acid moiety conjugated to the N-terminus for enhanced metabolic stability. This modification extends its plasma half-life relative to native GHRH while preserving high-affinity binding to the GHRH receptor (GHRH-R).\u003c\/p\u003e\u003cp\u003eTesamorelin is a clinically validated compound (FDA-approved as Egrifta for HIV-associated lipodystrophy), providing an extensive pharmacological and pharmacokinetic dataset for research context. Preclinical research examines its role in pulsatile GH secretion, IGF-1 pathway modulation, lipid metabolism, and neuroendocrine function. Its high receptor selectivity makes it a valuable tool for GHRH-R pathway investigation.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 218949-48-5  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~5135.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e GHRH-R pharmacology · Pulsatile GH secretion · IGF-1 signalling · Lipid metabolism · Lipodystrophy models · Neuroendocrine function\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=tesamorelin+GHRH+growth+hormone+lipodystrophy\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Tesamorelin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109185642829,"sku":null,"price":35.0,"currency_code":"GBP","in_stock":true},{"title":"8.88mg","offer_id":54162039734605,"sku":null,"price":47.5,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53109185675597,"sku":null,"price":65.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Tesamorelin5mgBox-M.jpg?v=1770812162"},{"product_id":"ipamorelin","title":"Buy Ipamorelin Research Peptide UK | 99%+ Purity","description":"\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) is a synthetic pentapeptide and the first truly selective growth hormone secretagogue (GHS), developed as a tool to distinguish GHRP-mediated GH release from off-target ACTH, cortisol, and prolactin stimulation seen with earlier GHRPs such as GHRP-2 and GHRP-6. It acts as a potent, selective agonist at the ghrelin receptor (GHS-R1a).\u003c\/p\u003e\u003cp\u003eIpamorelin's exceptional GH-specificity makes it particularly valuable in research on the ghrelin\/GHS-R1a axis, pituitary somatotroph function, and GH\/IGF-1 pathway modulation without the confounding endocrine effects of less selective GHRPs. Pharmacokinetic studies in humans have characterised its dose-proportional GH stimulation profile, short half-life (~2 h), and clean endocrine selectivity profile.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 170851-70-4  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C38H49N9O5  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 711.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e GHS-R1a \/ ghrelin receptor pharmacology · Selective GH secretagogue · Pituitary somatotroph biology · GH\/IGF-1 pathway · Endocrine selectivity studies · Metabolic research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin: the first selective growth hormone secretagogue (PMID 9849822)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/\" target=\"_blank\" rel=\"noopener\"\u003ePK\/PD modelling of ipamorelin in human volunteers (PMID 10496658)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19289567\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin as a novel ghrelin mimetic (PMID 19289567)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"Default Title","offer_id":53425666195789,"sku":null,"price":35.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Ipamorelin5mg-M.jpg?v=1772090649"}],"url":"https:\/\/www.peptide-biosciences.com\/collections\/growth-hormone-gh-releasing-research-peptides-uk.oembed","provider":"Peptide Biosciences","version":"1.0","type":"link"}